Current Position:
SrExecutive at Intas PharmaceuticalsExperience:
12 yearsLocation:
Ahmedabad, GujaratApr 2024 - Current
Dec 2013 - Jun 2020
Dec 2013 - Jun 2020
Master's degree at Gujarat University
BSc at St. Xavier's College, Ahmedabad
Name: Intas Pharmaceuticals
Speciality: Biosimilars Development, Recombinant Proteins Manufacturing, Central Nervous System, Cardio-Diabeto, Plasma Products, Women's Health, Animal Health, Chronic Therapies, Pharmaceuticals, Research and Development, Oncology, Animal Health, Gastroenterology, Urology, Auto immune, Rheumatology, Nephrology, Generic medicine, NDDS products, Hormone based therapies
Location: Ahmedabad, Gujarat, India
Employees: 10000+
Description: Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which ...
How long has Paresh Koriya been working as a SrExecutive?
Paresh Koriya's total experience in various companies as a SrExecutive 1 year 5 months.What is Paresh Koriya's minimum period of employment in the companies?
Paresh Koriya's minimum period of employment in various companies is 6 years 6 months.What is Paresh Koriya's average duration of employment for different companies?
On average, Paresh Koriya works for one company for 6 years 6 monthsWhat industries has Paresh Koriya worked in?
Paresh Koriya works in the Pharmaceuticals. Previously, Paresh Koriya worked in the Medical Devices.What positions has Paresh Koriya held before?
Previously, Paresh Koriya worked as a jrExecutive, and Associate.How do I contact Paresh Koriya?
Paresh Koriya's email address is k***********h@intaspharma.com, phone number is +91-***-***-4134. Sign up to get contact details.Who is the President/CEO/Director of the Intas Pharmaceuticals?
The President/CEO/Director of the Intas Pharmaceuticals is Kuldeep KarnikWho are Paresh Koriya's peers at other companies?
Paresh Koriya's peers at other companies are Hasib Meem and Indrani Paul and Mehedi Hasan RonyFind email for 850M+ professionals